Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Endocrinology
Volume 2015, Article ID 932372, 3 pages
http://dx.doi.org/10.1155/2015/932372
Case Report

Acute-on-Chronic Kidney Injury in Thyroid Hormone Withdrawal: A Case with Possible Implications for Radioactive Iodine Planning

1Division of Endocrinology and Metabolism, Rush University Medical Center, Chicago, IL 60612, USA
2Division of Endocrinology, Diabetes and Metabolism, University of Miami Miller School of Medicine, Endocrine Section, Bruce W. Carter Veterans Affairs Medical Center, Miami, FL 33136, USA

Received 2 June 2015; Accepted 10 August 2015

Academic Editor: Suat Simsek

Copyright © 2015 Elizabeth A. McAninch and Violet S. Lagari. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. M. Rhee, G. A. Brent, C. P. Kovesdy et al., “Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients,” Nephrology Dialysis Transplantation, vol. 30, no. 5, pp. 724–737, 2015. View at Publisher · View at Google Scholar
  2. L. H. Mariani and J. S. Berns, “The renal manifestations of thyroid disease,” Journal of the American Society of Nephrology, vol. 23, no. 1, pp. 22–26, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. Y. Hataya, S. Igarashi, T. Yamashita, and Y. Komatsu, “Thyroid hormone replacement therapy for primary hypothyroidism leads to significant improvement of renal function in chronic kidney disease patients,” Clinical and Experimental Nephrology, vol. 17, no. 4, pp. 525–531, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. D. H. Shin, M. J. Lee, H. S. Lee et al., “Thyroid hormone replacement therapy attenuates the decline of renal function in chronic kidney disease patients with subclinical hypothyroidism,” Thyroid, vol. 23, no. 6, pp. 654–661, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. D. S. Cooper, G. M. Doherty, B. R. Haugen et al., “Revised American thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer,” Thyroid, vol. 19, no. 11, pp. 1167–1214, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. H. Duntas and B. Biondi, “Short-term hypothyroidism after levothyroxine-withdrawal in patients with differentiated thyroid cancer: clinical and quality of life consequences,” European Journal of Endocrinology, vol. 156, no. 1, pp. 13–19, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. B. Halverson, F. Kozin, L. M. Ryan, and A. R. Sulaiman, “Rhabdomyolysis and renal failure in hypothyroidism,” Annals of Internal Medicine, vol. 91, no. 1, pp. 57–58, 1979. View at Publisher · View at Google Scholar · View at Scopus
  8. V. J. Bernet, “Reversible renal insufficiency attributable to thyroid hormone withdrawal in a patient with type 2 diabetes mellitus,” Endocrine Practice, vol. 10, no. 4, pp. 339–344, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. R. P. Espiritu and M. N. Stan, “Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancer,” Endocrine Practice, vol. 14, no. 8, pp. 1023–1026, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. J. Lee, H.-Y. Lee, W. W. Lee, and S. E. Kim, “The effect of recombinant human thyroid stimulating hormone on sustaining liver and renal function in thyroid cancer patients during radioactive iodine therapy,” Nuclear Medicine Communications, vol. 35, no. 7, pp. 727–732, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. S. H. Kreisman and J. V. Hennessey, “Consistent reversible elevations of serum creatinine levels in severe hypothyroidism,” Archives of Internal Medicine, vol. 159, no. 1, pp. 79–82, 1999. View at Publisher · View at Google Scholar · View at Scopus